Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Hadapi rentannya emosi remaja, sekolah perlu kembangkan ekosistem empati

● Kasus kekerasan dan kematian remaja mencerminkan kegagalan sekolah membaca dan merespons kesehatan mental siswa.● Indonesia perlu mengembangkan ekosistem empati sesuai konteks budaya aga...

Meningkatnya cemaran antibiotik di perairan dunia bisa membuat bakteri makin kebal

Antibiotik dan obat lainnya yang mencemari lingkungan bisa menyebabkan bakteri lebih kebal terhadap efek pengobatan.tawanroong/ShutterstockArtikel ini diterjemahkan dari bahasa Inggris untuk mempering...

Potret tragis para korban PHK di tengah maraknya perusahaan pailit

● Laporan PUSHAM UII atas kasus kepailitan menunjukkan deindustrialisasi nasional memang nyata.● Para pekerja yang terkena PHK, terutama akibat kepailitan, tidak memiliki kepastian mendapa...